Latest News about GALT
Recent news which mentions GALT
12 Healthcare Stocks Moving In Tuesday's Pre-Market Session
October 27, 2020
From Benzinga
12 Healthcare Stocks Moving In Friday's Pre-Market Session
October 02, 2020
From Benzinga
61 Biggest Movers From Yesterday
October 01, 2020
From Benzinga
20 Healthcare Stocks Moving In Wednesday's Intraday Session
September 30, 2020
From Benzinga
51 Stocks Moving In Wednesday's Mid-Day Session
September 30, 2020
From Benzinga
58 Biggest Movers From Yesterday
September 29, 2020
From Benzinga
72 Biggest Movers From Yesterday
May 01, 2020
From Benzinga
61 Stocks Moving In Thursday's Mid-Day Session
April 30, 2020
From Benzinga
From Benzinga
108 Biggest Movers From Yesterday
April 30, 2020
From Benzinga
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates
March 18, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 12, 2020
From Benzinga
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
February 28, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 27, 2020
From Benzinga
The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
February 27, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 26, 2020
From Benzinga
The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates
February 26, 2020
From Benzinga
94 Biggest Movers From Yesterday
February 12, 2020
From Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
February 11, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 10, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares
February 04, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 31, 2020
From Benzinga
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
January 31, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 30, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
January 30, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.